Michael Hübner,

New Venture Lead, Switzerland & Oncology

Michael Hübner is New Venture Lead at Johnson & Johnson Innovation, where he is responsible for establishing partnerships with life science companies. His focus is on Switzerland where he is scouting across all Johnson & Johnson healthcare business areas, as well as on therapeutics for oncology in the EMEA region.

Prior to joining Johnson & Johnson, Michael was Business Development and Licensing Manager at F.Hoffmann-La Roche where he led the scientific assessment and Due Diligence of preclinical and clinical stage external programs, and he scouted for innovative research at scientific and partnering conferences globally. During his time at Roche, he closed licensing and acquisition deals totaling over 1bn Euros.

Before joining Roche, Michael was a scientist at Cold Spring Harbor Laboratory (USA), where he worked as an EMBO fellow and DAAD scholar. Michael earned a PhD summa cum laude from the European Molecular Biology Laboratory (EMBL), and a Diploma in biochemistry from Tübingen University (Germany).


Michael Hübner
Michael Hübner